$HSGX: Histogenics’ (HSGX) CEO Adam Gridley on Q3 2018 Results …

Date: Saturday, November 10th, 2018

Stock(s) mentioned:

Source: Seeking Alpha (https://seekingalpha.com)

Summary: Histogenics Corporation (NASDAQ:HSGX) Q3 2018 Earnings Conference Call November 8, 2018 8:30 AM ET. Executives. Jon Lieber – Chief Financial Officer.

Full article address: https://seekingalpha.com/article/4220807-histogenics-hsgx-ceo-adam-gridley-q3-2018-results-earnings-call-transcript

Related News:

$HSGX $MRK: The Week Ahead In Biotech: ASH 2018, PDUFA Dates, Clinical …

$HSGX: Histogenics up 8% premarket

$HSGX: Histogenics slips 4% after hours on delist notice

$HSGX: Histogenics nets $15.4M in equity offering

$HSGX: Histogenics down 41% on pricing public offering of common stock …

$HSGX: Histogenics Corporation Announces Pricing of Public Offering of …

Latest News:

$BEL: Luxury Hotel News: Louis Vuitton Expands Into Hotels And Travel

$FNSR $IIVI: FINISAR INVESTOR ALERT by the Former Attorney General of …

$COST: A Bull And Bear Analyze Costco’s Q1 Earnings Print

$ATHN: ATHENAHEALTH INVESTOR ALERT by the Former Attorney …

$AIN: Albany International Declares Dividend

$NRZ: New Residential bounces as KBW advises buying the dip

$GE: GE says it may replace KPMG as auditor

$BEL: Why Belmond Ltd’s Shares Jumped 40% Today

$BA: Boeing delivers its 787th 787 Dreamliner

$F: Tariff Buzz Gives Ford a Lift

$JNJ: Johnson & Johnson Under Fire After Claims of Asbestos in Baby …